What Is Sempulse NIBP

The Blood Pressure Problem That Every Cuff Has Failed to Solve

Blood pressure is among the most clinically important vital signs in medicine. Yet after more than a century of monitoring technology, the standard approach still requires stopping, inflating, holding still, and waiting, episodically, in controlled conditions. Sempulse is building the technology to change that.

📈

Continuous, Not Episodic

Traditional oscillometric cuffs measure blood pressure at a point in time, typically every few minutes at best, and only when the patient is still. Hemodynamic deterioration, hypertensive surges, and orthostatic changes can occur and resolve between readings. Sempulse's cuffless NIBP is designed to provide a second-by-second blood pressure trend rather than a periodic snapshot. NIBP is under FDA review and not currently cleared.

⚙

Pulse Wave and Machine Learning

Sempulse's NIBP uses cardiovascular timing signals from Halo™'s proprietary multi-sensor architecture at the ear and neck, processed through machine learning trained on validated clinical data. The physiologic relationship between arterial hemodynamics and pulse wave propagation is well-established in cardiovascular physiology research. This approach produces continuous MAP, systolic, and diastolic blood pressure without cuff inflation. NIBP is under FDA review.

🚦

MAP, Systolic, and Diastolic

The target NIBP output covers all three clinically actionable blood pressure parameters: mean arterial pressure (MAP), systolic blood pressure (SBP), and diastolic blood pressure (DBP), with a target accuracy of ±3 mmHg each. These targets are specified per ISO 81060-2 and IEC 80601-2-30 standards. All accuracy values are development targets, not cleared specifications. NIBP is under FDA review and not currently cleared.

The Clinical Problem

Why Blood Pressure Cuffs Fail in the Settings That Need BP Most

The environments where continuous blood pressure information would be most valuable, including battlefield triage, trauma transport, prolonged field care, MASCAL response, and overnight hospital monitoring, are precisely the environments where cuff-based measurement is least practical.

The Problem: Traditional Cuff Blood Pressure

Why Cuffs Fail in Field and Clinical Settings

  • Requires patient stillness during cuff inflation, making it impossible during movement, transport, or active care.
  • Requires an uninjured arm: in trauma, the limb needed for cuff placement may be injured, inaccessible, or occupied with IV access.
  • Episodic measurement only: blood pressure can deteriorate and recover between readings without triggering any alert.
  • Wakes sleeping patients: inflation noise and pressure disrupt sleep, costing patients recovery time and elevating stress hormones.
  • Extremity peripheral vasoconstriction under physiologic stress degrades accuracy at exactly the moment accuracy matters most.
  • Requires a trained provider to apply and interpret; adds time and attention to already-constrained care workflows at MASCAL tempo.
  • Cannot provide a continuous hemodynamic trend for MEDEVAC triage, resuscitation guidance, or decompensation warning.
The Solution: Sempulse Cuffless NIBP (Under FDA Review)

What Continuous Cuffless BP Would Enable

  • Continuous second-by-second blood pressure trend during patient movement, transport, extraction, and CASEVAC.
  • No arm required: Halo™ monitors from the ear and neck, sites unaffected by arm injury or IV access.
  • Automatic threshold alerts when blood pressure crosses clinically significant levels, without manual checks.
  • Silent monitoring during sleep: patients rest undisturbed while continuous BP surveillance continues.
  • Central vascular placement at the ear and neck maintains signal fidelity under physiologic stress and vasoconstriction.
  • Single-device integration with all other Halo™ cleared vital signs: one wearable, one data stream, complete hemodynamic picture.
  • Longitudinal BP trends across evacuation, transport, resuscitation, and recovery, from point of injury through garrison.

All NIBP capabilities listed are under FDA review and not currently cleared or available commercially.

±3
mmHg target accuracy
MAP, systolic, diastolic
5
Clinical trial sites
in the validation program
1Hz
Target continuous BP
update rate
0
Cuff inflation events
required

NIBP is under FDA review and not currently cleared. ±3 mmHg is a development target per ISO 81060-2 standards, not a cleared specification.

How It Works

How Cuffless Blood Pressure Works on Halo™

1

The Physiology of Pulse Wave Travel

When the heart contracts, a pressure wave travels through the arterial system. The time it takes for this wave to travel from the heart to a peripheral measurement site is related to arterial wall stiffness. As blood pressure rises, arteries stiffen and pulse waves travel faster; as pressure falls, they slow. This relationship, established across decades of cardiovascular physiology research, is the physiologic basis for non-invasive continuous blood pressure estimation from pulse timing.

2

Continuous Cardiovascular Timing from Halo™ Multi-Sensor Architecture

The Halo™ wearable captures precise cardiovascular timing signals using its proprietary combination of ECG, PPG, and SCG sensors operating on a synchronized common clock with less than 1 millisecond error. The relationship between these timing signals and blood pressure is established in the cardiovascular physiology literature. This multi-sensor approach provides superior signal fidelity compared to single-sensor timing estimation, which is susceptible to motion and physiologic noise. The underlying sensor parameters contribute to outputs under FDA review.

3

Machine Learning Maps Cardiovascular Timing to Blood Pressure

Machine learning algorithms trained on validated clinical data from multiple populations and conditions map the continuous cardiovascular timing signal to MAP, systolic, and diastolic blood pressure estimates. The models account for individual physiologic variation, motion artifacts, and confounding signals. Training data spans the multi-site clinical trial program including Clinimark and Texas State University. NIBP is under FDA review and not currently cleared.

4

Continuous Output to LiveCharts and Command Cloud

When cleared, NIBP will stream continuously to LiveCharts alongside all other Halo™ vital signs at 1 Hz, integrated into the patient acuity sort and alarm system. Blood pressure threshold alerts will trigger at user-defined levels without requiring manual checks. Command Cloud will aggregate longitudinal BP trends across patient populations for post-event review and research. NIBP is under FDA review and not currently cleared.

The Science Foundation

FDA-Cleared Sensors. Cuffless BP Under Review.

ECG, PPG & SCG Sensors FDA Cleared

Halo™'s multi-sensor architecture captures synchronized cardiovascular signals at the ear and neck with sub-millisecond timing precision, providing the signal inputs that underlie NIBP estimation.

Central Vascular Placement

The ear and neck maintain central vascular perfusion under physiologic stress. Unlike extremity devices, Halo™ captures signals where blood flow is preserved during trauma and compensation, critical for trauma-relevant blood pressure estimation.

Machine Learning on Clinical Data

ML algorithms trained on Clinimark and Texas State University clinical validation data map cardiovascular timing to blood pressure estimates. Under FDA review.

NIBP Output: MAP, Systolic, Diastolic Under Review

Target accuracy ±3 mmHg per ISO 81060-2 and IEC 80601-2-30. Clinical trials underway. Not currently cleared.

Sleep and Recovery

Sleep Is the Best Medicine. Stop Waking Patients to Check Blood Pressure.

Sleep is not a passive state. It is when the body performs its deepest repair work: clearing metabolic waste from the brain, consolidating immune function, repairing tissue, and restoring cardiovascular homeostasis. Every interruption costs the patient something real.

In hospital settings, patients have their blood pressure checked manually every one to four hours through the night. Each inflation wakes the patient. Each wake costs sleep architecture continuity. Fragmented sleep elevates cortisol, impairs immune function, slows healing, and increases pain perception. This is not incidental: it is a structural flaw in how vital signs monitoring currently works.

In the field and in prolonged field care, a medic manually checking blood pressure on a sleeping casualty may shift them, trigger pain, or alert nearby threats. None of these outcomes serve the patient or the mission.

When Sempulse's cuffless NIBP receives FDA clearance, a patient wearing the Halo™ device will be continuously monitored for blood pressure throughout the night, in silence, without inflation, without waking, without handling. Clinicians and medics receive alerts only when a threshold is crossed. The patient sleeps. Care continues.

NIBP is under FDA review and not currently cleared. All NIBP benefits described are prospective, contingent on FDA clearance.

Why Nocturnal BP Matters

Clinical Value Beyond the Wakeup Check

Nocturnal Hypertension

Blood pressure that fails to dip during sleep (non-dipping pattern) is associated with increased cardiovascular event risk. This pattern is invisible to episodic daytime measurement and can only be captured with continuous overnight monitoring.

Hemodynamic Decompensation During Sleep

In post-operative, trauma recovery, and prolonged field care settings, blood pressure deterioration can occur silently during sleep before other vital signs reflect it. Continuous NIBP enables detection without manual observation.

Resuscitation Endpoint Monitoring

Maintaining target MAP during resuscitation from hemorrhagic shock or sepsis requires continuous blood pressure data. Episodic cuff checks introduce delays that continuous wearable NIBP eliminates.

Field Triage Without Waking Casualties

In PFC and austere settings, waking a casualty to check BP uses medic time, may worsen pain, and can increase intracranial pressure in TBI patients. Continuous wearable NIBP eliminates the wakeup entirely.

All NIBP capabilities are under FDA review and not currently cleared.

Anticipated Use Cases

Where Continuous Cuffless Blood Pressure Will Matter Most

All use cases below are contingent on FDA clearance of Sempulse's NIBP capability, which is currently under review and not cleared.

TCCC / Field Triage

Continuous BP at Point of Injury

Blood pressure during MARCH assessment without requiring a cuff on an injured limb. Continuous MAP tracking during hemorrhage control and resuscitation. Real-time hemodynamic trend during CASEVAC and MEDEVAC transport. Under FDA review.

Prolonged Field Care

Overnight BP Without Waking the Casualty

Blood pressure monitoring throughout extended casualty care periods without manual checks or patient disturbance. Alert-based thresholds wake the medic, not the patient. Longitudinal MAP trends support resuscitation and fluid management decisions. Under FDA review.

EMS / Ambulance

Continuous BP During Transport

Blood pressure monitoring throughout the transport interval, including during turbulence, patient movement, and CPR. No cuff re-inflation required. Integrated with all other Halo™ cleared vitals in a single data stream to LiveCharts and Command Cloud. Under FDA review.

Hospital / ICU

Continuous Hemodynamic Monitoring Without Arterial Line

Continuous non-invasive BP for patients who require hemodynamic monitoring but for whom arterial line placement is not indicated. Silent overnight monitoring without cuff interruption. MAP trend during post-operative recovery, sepsis management, and resuscitation endpoints. Under FDA review.

Remote Patient Monitoring

At-Home Hypertension and Cardiovascular Management

Ambulatory blood pressure monitoring without a dedicated ambulatory BP cuff device. Nocturnal BP dipping pattern capture. 24-hour BP variability for hypertension management, medication titration, and cardiovascular risk assessment. Under FDA review.

Research

Continuous BP for Clinical and Physiologic Research

Continuous MAP, systolic, and diastolic BP at 1 Hz across extended study periods, without the burden of ambulatory cuff devices on subjects. Integration with HaloCRM™ reserve monitoring, ECG, and full Halo™ vital signs suite for multi-parameter cardiovascular physiology studies. Under FDA review.

Clinical Validation Program

Multi-Site Clinical Trial Partners

Sempulse's NIBP clinical validation program involves multiple validated clinical sites building the evidence package for the NIBP 510(k) FDA submission.

Clinimark

FDA-recognized independent clinical testing laboratory. Providing rigorous ISO 81060-2 protocol clinical validation for the NIBP 510(k) submission across varied patient populations and conditions.

Texas State University

Research university clinical partner providing validation data in support of the NIBP development and 510(k) submission program.

USAISR LBNP Laboratory

Ongoing hemodynamic validation at the U.S. Army Institute of Surgical Research Lower Body Negative Pressure laboratory, using the ASME V&V 40-validated hemorrhage equivalence model to characterize NIBP and HaloCRM™ performance under simulated hemorrhage conditions.

NIBP is under FDA review. Clinical trial sites are listed as validation partners; clinical trial data does not constitute FDA clearance.

Frequently Asked Questions

Cuffless NIBP: Austere Medicine, Emergency Medicine, and Beyond

Answers to the most common questions from military medical professionals, critical care clinicians, emergency medicine providers, researchers, and biomedical engineers working on blood pressure monitoring technology.

Is Sempulse's cuffless NIBP FDA-cleared?+

No. This is the single most important fact on this page. Sempulse's cuffless non-invasive blood pressure (NIBP) monitoring is currently under FDA review and is not FDA-cleared. It is not available for commercial use as a blood pressure measurement device today.

The Sempulse Halo™ monitor is FDA-cleared under K232495 for more than 20 vital sign parameters, but blood pressure measurement is not among the currently cleared outputs. Clinical trials are underway at multiple validated sites in support of the NIBP 510(k) submission. Sempulse anticipates clearance in 2026 or 2027, subject to FDA review timelines. FDA timelines are not guaranteed.

How does cuffless blood pressure measurement work?+

Cuffless blood pressure estimation uses the well-established relationship between arterial hemodynamics and how quickly a pressure wave travels through the vascular system. As blood pressure rises, arteries stiffen and waves travel faster; as it falls, they slow. By capturing precise cardiovascular timing signals from the Halo™ wearable's synchronized multi-sensor architecture at the ear and neck, and processing those signals through machine learning algorithms trained on validated clinical data, the system estimates MAP, systolic, and diastolic blood pressure continuously without cuff inflation.

Sempulse's implementation uses FDA-cleared ECG, SCG, and PPG sensors on the Halo™ device, operating on a synchronized clock with less than 1 millisecond error. The NIBP output is under FDA review and not currently cleared.

Can continuous NIBP prevent waking sleeping patients to check blood pressure?+

That is exactly the clinical goal, and it is one of the most compelling reasons this technology matters. Sleep is a primary healing mechanism. Every interruption for a manual blood pressure check costs the patient sleep quality, elevates stress hormones, fragments sleep architecture, and introduces unnecessary discomfort. In hospitals, patients may be woken hourly for vital signs checks through the night. In prolonged field care, manual BP checks may disturb a wounded casualty who desperately needs rest.

When Sempulse's cuffless NIBP receives FDA clearance, a patient wearing the Halo™ device will be continuously monitored for blood pressure throughout the night without inflation, without noise, without waking, and without any physical interaction from a provider. Clinicians receive alerts only when a threshold is crossed. The patient sleeps. Clinical vigilance continues. NIBP is under FDA review and this benefit is contingent on clearance.

What are the target accuracy specifications for Sempulse's NIBP?+

Sempulse's development target is ±3 mmHg accuracy for MAP, systolic, and diastolic blood pressure. These targets are specified per ISO 81060-2 (non-invasive sphygmomanometer clinical validation) and IEC 80601-2-30 (medical electrical equipment for automated non-invasive sphygmomanometers) standards. These are development targets for the clinical program, not cleared performance specifications. NIBP is under FDA review and not currently cleared.

Why does blood pressure monitoring fail in trauma and field triage?+

Traditional oscillometric cuff-based blood pressure measurement requires patient stillness during inflation, an uninjured and accessible arm, and periodic episodic check-ins rather than continuous monitoring. In field triage, TCCC, prolonged field care, EMS transport, and MASCAL settings, all of these requirements frequently cannot be met simultaneously.

Beyond the mechanical limitations, blood pressure itself is a lagging indicator of hemodynamic deterioration during hemorrhage. The body's compensatory mechanisms maintain blood pressure within normal ranges during early hemorrhage even as true cardiovascular reserve depletes. This is why HaloCRM™ compensatory reserve monitoring (also under FDA review) is designed to detect decompensation earlier than blood pressure alone. Continuous cuffless NIBP combined with HaloCRM™ represents a more complete hemodynamic monitoring solution than either parameter provides independently.

What does blood pressure during sleep tell clinicians that daytime readings miss?+

Nocturnal blood pressure patterns contain clinically meaningful information that daytime measurement cannot capture. Blood pressure normally dips 10 to 20 percent during sleep; patients who fail to show this dip (non-dippers) have significantly elevated cardiovascular event risk even when daytime blood pressure appears controlled. Identifying this pattern requires continuous overnight monitoring, which traditional cuff-based ambulatory blood pressure monitoring devices provide only approximately every 15 to 30 minutes through the night, with each measurement waking the patient.

Continuous cuffless NIBP would provide a second-by-second nocturnal blood pressure profile without any patient disturbance, capturing dipping patterns, hypertensive surges, and hemodynamic instability that episodic measurement misses entirely. NIBP is under FDA review and this capability is contingent on FDA clearance.

Where are the clinical trials for Sempulse NIBP being conducted?+

Sempulse's NIBP clinical validation program includes Clinimark (an FDA-recognized independent clinical testing laboratory) and Texas State University. The USAISR LBNP laboratory also contributes hemodynamic validation data under simulated hemorrhage conditions. This program is designed to build the clinical evidence package for the NIBP 510(k) FDA submission.

How does Sempulse's NIBP relate to HaloCRM™ compensatory reserve monitoring?+

These are complementary, not competing, capabilities. HaloCRM™ compensatory reserve monitoring detects hemodynamic deterioration earlier than blood pressure can, because it measures the reserve being consumed by the body's compensatory response rather than the blood pressure that response is temporarily maintaining. Blood pressure is a lagging indicator during early hemorrhage; compensatory reserve is an earlier one.

Continuous cuffless NIBP adds the explicit blood pressure picture that HaloCRM™ provides context for. Together, a provider would have both the early warning signal (CRM declining before BP changes) and the traditional clinical hemodynamic parameter (BP) in continuous real-time, from a single 17-gram wearable with no cuff required. Both capabilities are under FDA review and not currently cleared.

Get in Touch

Interested in Sempulse NIBP?

Contact Sempulse to discuss the NIBP development program, clinical trial participation, evaluation access, or integration into your research or clinical program.

Contact Sempulse See FDA-Cleared Halo™ Vitals

IMPORTANT: Sempulse NIBP is under FDA review and is NOT currently FDA-cleared. It is not available for commercial use as a blood pressure measurement device. The Sempulse Halo™ monitor is FDA-cleared under K232495 for vital signs monitoring; blood pressure measurement is not among the currently cleared parameters. No NIBP capability should be implied from the purchase or use of the current Halo™ device. Halo™ is an applied-for trademark of Sempulse Corporation.

Cuffless Blood Pressure: A Revolution in Continuous Monitoring with Sempulse Halo, LiveCharts, and Command Cloud

Cuffless blood pressure monitoring is reshaping the way we think about health monitoring, particularly for patients who require regular or continuous observation of their vital signs. In the past, measuring blood pressure relied on devices that used a sphygmomanometer cuff to compress the arm, allowing for systolic and diastolic pressures to be recorded. While this method is widely used and considered reliable, it comes with certain drawbacks. For one, it can be uncomfortable, especially when the cuff inflates to squeeze the arm. It also offers only intermittent readings, which may not reflect fluctuations throughout the day. More recently, the healthcare industry has seen a move towards non-invasive, cuffless blood pressure monitoring, driven by technological advancements in sensors and data analytics.

Sempulse, with its innovative products like the Halo, LiveCharts, and Command Cloud, is at the forefront of this shift towards more comfortable, accurate, and continuous non-invasive blood pressure (NIBP) monitoring. The Sempulse Halo is a lightweight, wearable device that attaches to the back of the ear and the side of the neck, allowing it to monitor vital signs such as blood pressure, pulse rate, and SpO2 oxygen saturation in real-time. It employs sophisticated algorithms and non-invasive sensors, offering an alternative to traditional cuff-based blood pressure monitoring.

At the core of this technology is the ability to measure blood pressure without the need for a cuff. Devices like the Halo rely on methods such as pulse transit time (PTT) and pulse arrival time (PAT) to estimate blood pressure. PTT refers to the time it takes for a pulse wave to travel between two points in the body—typically from the heart to a peripheral site, like the wrist or the ear. PAT, on the other hand, is the time interval between the electrical signal that triggers a heartbeat (detected by an electrocardiogram, or ECG) and the arrival of the pulse at a peripheral sensor. PAT includes an additional factor, the pre-ejection period (PEP), which is the time it takes for the heart to pump blood into the arteries. This means that while PAT is a useful metric, PTT is often considered more accurate for blood pressure estimation, as it is more directly correlated with blood pressure changes.

One of the advantages of the Sempulse Halo is its ability to offer continuous blood pressure monitoring. Traditional cuff-based monitors can only provide readings at specific moments in time, which may miss significant changes in blood pressure that occur between measurements. By contrast, the Halo provides real-time data, allowing healthcare providers and patients to observe trends and fluctuations throughout the day. This continuous monitoring is particularly important for patients with hypertension or other cardiovascular conditions, where changes in blood pressure can provide critical insights into their health.

The back of the ear is an ideal location for the Halo device due to its proximity to several large blood vessels, including the carotid artery. This allows for more accurate detection of pulse waves and other vital signs. The ear is also a stable location, reducing the likelihood of noise or interference in the readings, which can occur when sensors are placed on more mobile parts of the body, such as the wrist. In addition, the ear provides a convenient and comfortable location for long-term monitoring, as the device is small and lightweight, making it suitable for extended wear.

The technology behind cuffless blood pressure monitoring is grounded in photoplethysmography (PPG), a non-invasive method that uses light to measure changes in blood volume in the microvascular tissue called the PPG waveform. PPG sensors detect these changes by analyzing the way light is absorbed through the skin, which fluctuates as blood flows through the arteries. By combining PPG signals with other data, such as ECG, PTT, or PAT, devices like the Halo can estimate blood pressure without the need for a cuff.

Another key feature of the Sempulse Halo is its integration with the LiveCharts app, which provides real-time visualization of the data collected by the device. This allows users to track their blood pressure, pulse rate, and other vital signs over time, making it easy to observe trends and identify any potential issues. The app can also send notifications if the user’s blood pressure readings fall outside of normal parameters, helping to alert them to potential health concerns before they become serious. For healthcare providers, this real-time data can be invaluable in making more informed decisions about a patient’s treatment.

For clinicians managing multiple patients, the Command Cloud platform offers a powerful tool for remote monitoring. Command Cloud allows healthcare providers to track the vital signs of numerous patients simultaneously, making it easier to manage care for those with chronic conditions or those recovering from surgery. This remote monitoring capability is particularly useful for reducing the need for in-person visits, as it enables clinicians to keep a close eye on their patients’ health from afar.

One of the biggest concerns surrounding cuffless blood pressure devices is their accuracy compared to traditional cuff-based systems. While cuff-based monitors are still considered the gold standard, they do not represent true internal blood pressure, sometimes called mainline blood pressure. Cuffless devices have become increasingly accurate to true blood pressure thanks to advances in sensor technology and machine learning algorithms. Cuffless devices may require calibration against a standard cuff-based measurement, but the Halo’s sophisticated algorithms reduce the need for continued calibration, making it a convenient option for long-term use.

These devices are also undergoing clinical validation to ensure they meet the stringent standards set by regulatory bodies such as the Food and Drug Administration (FDA) and international organizations like the European Society of Hypertension Working Group. Ongoing clinical trials and studies are continuously improving the accuracy and reliability of cuffless blood pressure monitors, and Sempulse is at the forefront of these developments.

The science behind cuffless blood pressure monitoring is complex, but the benefits are clear. As technology continues to evolve, devices like the Sempulse Halo offer the potential to revolutionize healthcare by providing more accurate, convenient, and continuous monitoring of vital signs. This is particularly important for patients with cardiovascular diseases or other conditions that require regular monitoring. The ability to track blood pressure without a cuff, and in real-time, represents a significant leap forward in healthcare technology.

As the healthcare landscape continues to shift towards remote patient monitoring, the role of devices like the Sempulse Halo will only grow in importance. By providing continuous, non-invasive monitoring, the Halo not only improves patient comfort but also offers healthcare providers the tools they need to make more informed decisions and intervene earlier when necessary. This combination of real-time data, clinical accuracy, and wearable comfort positions Sempulse as a leader in the field of cuffless blood pressure monitoring, setting a new standard for patient care in the digital age.

What is Cuffless Blood Pressure?

Cuffless blood pressure refers to the method of measuring blood pressure without using the traditional inflatable arm cuff. Historically, blood pressure has been measured using a sphygmomanometer, which requires a cuff to be wrapped around the upper arm, inflated to restrict blood flow, and then gradually deflated to measure systolic and diastolic pressure. While accurate, this method is inconvenient for continuous monitoring and can cause discomfort, especially for long-term measurements.

Cuffless technology instead relies on sensors and algorithms to estimate blood pressure using signals such as pulse wave velocity (PWV), electrocardiography (ECG), pulse arrival time (PAT), pulse transit time (PTT), and photoplethysmography (PPG), among others. These technologies make it possible to monitor blood pressure continuously without requiring patients to stop and apply a cuff.

How do Medical Devices Measure Blood Pressure Without a Cuff?

Several different techniques and sensors are used in cuffless devices to estimate blood pressure. Some of the key technologies include:

  • Photoplethysmography (PPG): PPG uses light to measure changes in blood volume in the microvascular bed of tissue. This technology is widely used in wearables for heart rate monitoring, but it can also be applied to blood pressure estimation when combined with other signals like ECG.
  • Electrocardiography (ECG): ECG is the process of producing an electrocardiogram, or a recording of the heart’s electrical activity through repeated cardiac cycles. It is an electrogram of the heart which is a graph of voltage versus time of the electrical activity of the heart using electrodes placed on the skin. When used alongside PPG, ECG can provide critical data for more accurate blood pressure readings.
  • Pulse Arrival Time (PAT): This measures the time interval between the electrical signal that triggers a heartbeat (detected by an electrocardiogram, or ECG) and the arrival of the pulse at a peripheral sensor.
  • Pulse Transit Time (PTT): This measures the time it takes for a pulse wave to travel between two points in the body, often from the heart to a peripheral artery. It correlates with blood pressure, as the speed of the pulse wave is affected by the stiffness of the arteries and the pressure of the blood inside them.
  • Pulse Wave Velocity (PWV): This refers to the velocity at which the pressure wave moves through the circulatory system. Similar to PTT, PWV is influenced by arterial stiffness and blood pressure, making it another useful parameter for cuffless monitoring.

By combining these technologies, modern cuffless devices like Sempulse Halo can continuously monitor blood pressure without the discomfort or inconvenience of traditional methods.

Are Cuffless Blood Pressure Monitors Accurate?

Accuracy is a primary concern when it comes to cuffless blood pressure monitors. While the technology is still evolving, there are already cuffless devices on the market that have demonstrated clinically acceptable accuracy. However, achieving the same level of accuracy as traditional cuff-based devices can be challenging, particularly for individuals with cardiovascular conditions or varying physiological responses.

Several studies have been conducted to validate the accuracy of cuffless devices, including trials with photoplethysmography (PPG) sensors and pulse transit time (PTT) analysis. The consensus is that while cuffless monitors can provide reliable trend data over time, they may not always be as precise as traditional devices for absolute blood pressure values. Nevertheless, the continuous nature of the monitoring makes them invaluable for tracking changes in blood pressure, which is often more critical for long-term patient care.

A validation protocol from the International Organization for Standardization (ISO) and the Advancement of Medical Instrumentation (AAMI) is typically used to ensure that cuffless devices meet the necessary accuracy standards. Sempulse’s Halo, for example, has undergone rigorous testing and validation to meet these high standards, making it one of the most reliable cuffless solutions available.

Is There a Wearable Device That Monitors Blood Pressure?

Yes and no, there are several wearable devices that have been cleared by the FDA but the FDA has since rescinded these clearances. None are available on the market today that monitor blood pressure without the need for a cuff. These devices used the technologies mentioned above, including PTT, PWV, and PPG, to estimate blood pressure from sensors worn on the wrist, chest, or finger, none of which are ideal locations for non-invasively monitoring vital signs.

Sempulse’s Halo wearable stands out because it provides real-time, continuous monitoring of vital signs, including blood pressure, from the back of the ear and the side of the neck without the need for repeated calibration or additional hardware. Paired with LiveCharts, a monitoring dashboard, and Command Cloud, which offers cloud-based data storage and analytics, Halo offers a seamless experience for healthcare providers and patients alike. This system is ideal for environments where constant blood pressure monitoring is necessary but applying and maintaining a traditional cuff is impractical, such as in remote patient care or first responder settings.

Is There a Blood Pressure Monitor That Does Not Need Calibration?

Most cuff-based blood pressure monitors require periodic calibration to ensure accuracy. Calibration involves comparing the readings from the device with a known standard to adjust for any drift in measurement over time. Cuffless devices, especially those that rely on sensors and algorithms, can sometimes require calibration to account for variations in the user’s physiology or the performance of the sensors.

However, newer cuffless devices like Sempulse Halo are designed to minimize or eliminate the need for frequent calibration. By using advanced algorithms and machine learning, these devices can self-correct and adapt to the patient’s individual baseline, ensuring accurate and reliable blood pressure measurements without the hassle of constant recalibration.

Are There Medical Device Wearables That Continuously Monitor Blood Pressure?

Yes, there are several wearable devices capable of continuously monitoring blood pressure, and Sempulse is a leader in this area. Continuous monitoring is essential for tracking trends and detecting potential health issues before they become critical. For instance, continuous blood pressure monitoring can help identify conditions like hypertension, hypotension, or even atrial fibrillation, providing an early warning to both patients and healthcare providers.

The Halo wearable from Sempulse offers continuous monitoring of not only blood pressure but also other vital signs like heart rate and oxygen saturation. This makes it an ideal tool for a range of medical applications, from human performance optimization (HPO) to managing chronic conditions in home healthcare or remote monitoring settings.

Can a Smartwatch Measure Blood Pressure?

No. There are several smartwatches on the market that claim to measure blood pressure, but the accuracy and reliability of these devices can vary significantly and none are cleared for use by the FDA. Most smartwatches use PPG sensors to estimate blood pressure, which can provide a general sense of trends but may not be as accurate as a medical-grade device and these types of pulse oximeters located on the extremities do not work during extreme conditions or trauma.

For example, while the Apple Watch can measure heart rate and detect irregular heart rhythms, its blood pressure monitoring capabilities are limited compared to dedicated medical devices. Sempulse Halo, on the other hand, is specifically designed for medical use and provides more accurate and continuous blood pressure monitoring than most consumer-grade wearables.

Do Any Smart Rings or Chest Straps Measure Blood Pressure?

No. Some companies are exploring the use of smart rings and chest straps for blood pressure monitoring, but these devices are still in the early stages of development and are unlikely to achieve FDA clearances. Most current solutions rely on wrist-based sensors or chest straps that measure heart rate, respiratory rate, or ECG, but incorporating accurate blood pressure monitoring remains a challenge. These are not ideal locations to monitor vital signs due to motion, hair, sweat, tattoos, and blood flow.

Sempulse Halo is unique in that it is a compact, wearable device that can be worn on the back of the ear and offers continuous, cuffless blood pressure monitoring. While not a ring or chest strap, its versatility and accuracy make it a superior choice for medical-grade blood pressure monitoring.

How Do I Know If My Blood Pressure Monitor is Accurate?

Accuracy is critical when it comes to blood pressure monitoring, especially for individuals with cardiovascular conditions or those at risk for hypertension. To ensure that your device is accurate, follow these steps:

  • Check for FDA approval: Devices that have been approved by the FDA have undergone rigorous testing to ensure they meet the necessary accuracy standards.
  • Look for validation protocols: Devices that adhere to standards set by organizations like the International Organization for Standardization (ISO) or the Advancement of Medical Instrumentation (AAMI) are more likely to be accurate.
  • Regularly compare readings: If you have access to a traditional cuff-based monitor, periodically compare the readings from your cuffless device to ensure they align.
  • Follow the manufacturer’s instructions: Proper use of the device is essential for accurate readings. Make sure you follow the instructions provided by the manufacturer, including where to place the device and how to interpret the readings.

Sempulse Halo has been thoroughly tested and validated to ensure that it provides accurate blood pressure readings. Its advanced algorithms and machine learning capabilities help it adapt to each individual user, making it one of the most reliable cuffless monitors on the market.

Cuffless blood pressure monitoring is revolutionizing the way healthcare providers and patients monitor blood pressure. With devices like the Sempulse Halo, clinicians can continuously track blood pressure and other vital signs in real-time without the need for cumbersome cuffs or repeated calibration. This technology holds enormous potential for improving patient outcomes, especially in settings like remote patient monitoring (RPM), human performance optimization (HPO), and chronic disease management. Simply not having to wake a patient up every hour in the hospital to check their vital signs would be a game changer.

By integrating cuffless technology into platforms like LiveCharts and Command Cloud, Sempulse offers healthcare providers a comprehensive solution for tracking patient health over time. As the technology continues to evolve, cuffless monitors like the Halo are poised to become the new standard in blood pressure monitoring.

For more information about cuffless blood pressure and the benefits of continuous, cuffless blood pressure monitoring, check out the FDA’s official site on Medical Wearables and Validation, the American Heart Association’s Blood Pressure Monitoring Guidelines, and the Mayo Clinic’s  The Future of Cuffless Blood Pressure.